Aging
Navigate
Correction|Volume 15, Issue 20|pp 11690—11691

Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen

Liang Wang1, Yinfeng Lyu2, Yuqing Li2, Kunping Li2, Hui Wen2, Chenchen Feng2, Ning Li3
  • 1Department of Urology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China
  • 2Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China
  • 3Department of Urology, Fourth Affiliated Hospital of China Medical University, Shenyang 100032, Liaoning Province, P.R. China
* Equal contribution
Received: October 16, 2023Accepted: October 27, 2023Published: October 30, 2023

Copyright: © 2023 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.